SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: phastmike who wrote (132)10/28/1997 8:43:00 AM
From: Richard Haugland  Read Replies (1) | Respond to of 337
 
VGINF reports its earnings for the third quarter

biz.yahoo.com

Mike, I am back in at 11 1/4 last week but looks like EVERYTHING may be cheaper soon.

We'll see if there is an response to the earnings or Monsec recommendation but I,m afraid everything will get buried with the overall market.



To: phastmike who wrote (132)10/29/1997 12:26:00 PM
From: scaram(o)uche  Respond to of 337
 
pHastone:

Montgomery is as powerful as you get in biotech. Do you know their major justifications for picking this target? Twenty five bucks sounds like a rather easy ride for a bit? Given the "season", a strong rec from MS can almost be self-fullfilling. Any excerpts to share?

Thanks.

Rick


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News